NGMDF
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.01 | $24,732 | -$1M |
| 2025 Q4 | -0.02 | $84,198 | -$1M |
| 2025 Q3 | -0.01 | $34,678 | -$1M |
| 2025 Q2 | -0.01 | $22,121 | -$762,930 |
| 2025 Q1 | 0.01 | $116,883 | -$819,508 |
| 2024 Q4 | 0.00 | $415,746 | -$3M |
| 2024 Q3 | -0.01 | $531,815 | -$893,555 |
| 2024 Q2 | -0.00 | $14,924 | -$214,557 |